Deficiency of glucose-6-phosphate dehydrogenase (G6PD) is the most common inherited metabolic enzyme disorder in the world, with a very high incidence throughout the tropics and subtropics as a result of malarial selection (1-3 ). More than 140 mutations or combinations of mutations of the X-linked gene for G6PD have been characterized at the DNA level from different ethnic populations worldwide (4,5 ). In areas of Southeast Asia, including southern China, at least 25 deficiency-causing point mutations have been identified in the human G6PD gene. Ten mutations (95A3 G, 392G3 T, 487G3 A, 493A3 G, 592C3 T, 871G3 A, 1024C3 T, 1360C3 T, 1376G3 T, and 1388G3 A) account for Ͼ80% of all known mutations in Southeast Asian countries (4 -8 ).The current molecular approaches to identifying G6PD-deficiency-causing mutations rely on various methods for allele differentiation (7-10 ). Each of these approaches has advantages and limitations, but the technical aspects and/or cost have limited their routine use in most laboratories. Rapid and accurate genotyping of G6PD-deficiency-causing mutations is necessary to meet the requirements for genetic counseling, genetic epidemiology, and clinical molecular diagnosis of this disorder.We have developed a multiplex primer extension/fully denaturing HPLC (PE/DHPLC) assay capable of simultaneously detecting the above 10 G6PD mutations and 1 common polymorphism (1311C3 T) (11 ). Eleven genomic DNA samples with different known genotypes, including the above 11 G6PD mutations and the silent polymorphism as previously determined by direct sequencing, were used to validate this application. A total of 209 blood samples with various G6PD-deficiency-causing mutations, the silent polymorphism, or the wild-type G6PD gene sequence identified by direct sequencing were obtained to test the specificity of this assay by blind analysis. The genotypes of these DNA samples are shown in Table 1 of the Data Supplement that accompanies the online version of this Technical Brief at http://www.clinchem. org/content/vol51/issue7/.Multiplex PCRs were designed to produce sequences of interest in the G6PD gene, to be used for detection by the PE reaction, and generated 370-, 967-, and 1041-bp fragments (GenBank accession number X55448), respectively. Eleven oligonucleotides for specific genotyping of the 11 different mutations were designed according to the previously published sequence [(4, 12 ); Table 1 and Fig. 1 in the online Data Supplement] and were used in 2 separate groups for multiplex PE. The basic principle for identification of point mutations by this method is PE-based specific detection (13 ). Because the separation of oligonucleotides by DHPLC is both size and sequence dependent under fully denaturing conditions, modification of some of the oligonucleotides was necessary to provide an easily interpretable genotype pattern (14 ). The multiplex PCR was performed in a total volume of 25 L containing 12.5 L of 2ϫ PCR Master Mix [including deoxynucleotide triphosphates (dNTPs), buffer, MgCl 2 , and ...